6. Parkinson disease
2,123 clinical trials,   2,046 drugs   (DrugBank: 324 drugs),   183 drug target genes,   198 drug target pathways
Searched query = "Parkinson disease"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT04218968 (ClinicalTrials.gov) | December 30, 2019 | 26/12/2019 | Cardiac Changes in Early Parkinson's Disease: A Follow up Study | The Effect of Adrenergic Blocker Therapy on Cardiac and Striatal Transporter Uptake in Pre-Motor and Symptomatic Parkinson's Disease: A Follow up Study | REM Sleep Behavior Disorder;Pre-motor Parkinson Disease;Symptomatic Parkinson Disease | Drug: Carvedilol | Cedars-Sinai Medical Center | NULL | Enrolling by invitation | 18 Years | 85 Years | All | 15 | Phase 2 | United States |
2 | NCT03775096 (ClinicalTrials.gov) | April 4, 2019 | 9/12/2018 | Adrenergic Blockers for Cardiac Changes in Early Parkinson's Disease | The Effect of Adrenergic Blocker Therapy on Cardiac and Striatal Transporter Uptake in Pre-Motor and Symptomatic Parkinson's Disease | REM Sleep Behavior Disorder;Pre-motor Parkinson Disease;Symptomatic Parkinson Disease | Drug: Carvedilol | Michele Tagliati, MD | NULL | Recruiting | 30 Years | 75 Years | All | 15 | Phase 2 | United States |